Produkty 128-33-6

CAS 128-33-6 występuje w naszej ofercie pod nazwami: Zymosterol, (3β,5α)-Cholesta-8,24-dien-3-ol, Zymosterol, 99.47%. Oferty producentów: Chemat Brand, TRC, TargetMol, Sigma-Aldrich, Chemat. Dostępne opakowania: on request, 50mg, 1mg, 5MG, 1 mg, 5 mg.

Zymosterol
Chemat Brand, TRC, TargetMol
  • opakowanie: on request, 50mg, 1mg, 5MG
  • Warianty: 5
od 2060,00
Zobacz produkt
(3β,5α)-Cholesta-8,24-dien-3-ol
Chemat
  • opakowanie: 1mg
  • Warianty: 1
od 2920,40
Zobacz produkt
Zymosterol, 99.47%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 1945,09
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 128-33-6) to związek chemiczny o wzorze sumarycznym C27H44O i masie molowej 384.6 g/mol. Nazwa systematyczna IUPAC: (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: CGSJXLIKVBJVRY-XTGBIJOFSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O
Masa molowa384.6 g/mol
Nazwa IUPAC(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyCGSJXLIKVBJVRY-XTGBIJOFSA-N
SMILESC[C@H](CCC=C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Zymosterol, 5alpha-Cholesta-8,24-dien-3beta-ol, 5-alpha-Cholesta-8,24-dien-3-beta-ol, delta8,24-Cholestadien-3beta-ol, 5 alpha-cholesta-8,24-dien-3 beta-ol, zymostrol, 5.alpha.-Cholesta-8,24-dien-3.beta.-ol, Cholesta-8,24-dien-3-ol, Cholesta-8,24-dien-3-ol #, Cholest-8,24-dien-3.beta.-ol
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-(trideuteriomethyl)hept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohex-3-en-1-ol C27H44O